Applied BioCode (TPE:6598) Buyback Yield % : -19.92 (As of Mar. 29, 2025)

View and export this data going back to 2017. Start your Free Trial

What is Applied BioCode Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Applied BioCode's current buyback yield was -19.92%.

Applied BioCode Buyback Yield % Historical Data

The historical data trend for Applied BioCode's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied BioCode Buyback Yield % Chart

Applied BioCode Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-14.68

-0.04

-0.01

-21.30

Applied BioCode Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-18.78	-21.30

Competitive Comparison of Applied BioCode's Buyback Yield %

For the Medical Devices subindustry, Applied BioCode's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied BioCode's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Applied BioCode's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Applied BioCode Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Applied BioCode's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	441.183)	/	2071.15805
	=	-21.30%

Applied BioCode's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	441.183)		/	2071.15805
	=	-21.30%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Applied BioCode Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Applied BioCode's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied BioCode Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Applied BioCode Corp (TPE:6598) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

12130 Mora Dr., Unit 2,, Santa Fe Springs, CA, USA, 90670

Website

https://www.apbiocode.com

Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.

Applied BioCode Headlines

No Headlines